Precision Health Initiative in the News - December 2021
In the last month, the IU Precision Health Initiative researchers have been in the news talking about topics such as a study for people with triple negative breast cancer, Alzheimer's disease research, COVID-19 boosters and new variants, a silicon nanochip that can reprogram biological tissue, and more.
Precision Health Initiative in the News - November 2021
In the last month, the IU Precision Health Initiative researchers have been in the news talking about topics such as the risks of going back to the office for people with Long COVID, how chief information officers are prioritizing artificial intelligence, diversity in breast cancer clinical trials, the PERSEVERE study, and more.
Third IU Precision Health Initiative webinar focuses on multiple myeloma progress
The third IU Grand Challenges webinar about the Precision Health Initiative (PHI) took place this week, focusing on progress in studying and treating multiple myeloma, which is a cancer of the plasma cells in blood. This webinar featured Rafat Abonour, MD, who leads the IU Precision Health Initiative multiple myeloma disease research team, as well as Dorothy Frapwell, a multiple myeloma patient and retired IU general counsel. IU Vice President for Research Fred Cate served as the event’s host.
IU Precision Health Initiative featured by Missouri news teams
The outcomes, impact and efforts made by the IU Precision Health Initiative recently resulted in a multimedia news crew traveling to Indianapolis from Columbia, Missouri, to talk with several leaders about precision health.
Precision Health Initiative in the News - October 2021
In the last month, the IU Precision Health Initiative researchers have been in the news talking about topics such as COVID-19 vaccines and the Delta variant, ethical considerations surrounding ivermectin treatment for COVID-19, addressing food shortages with insect farming, the importance of taking mental health days, and more.
Precision Health Initiative in the News - September 2021
In the last month, the IU Precision Health Initiative researchers have been in the news talking about topics such as a new study about herbicide and pregnant women, "smart" insulin that could improve diabetes treatment, a new artificial intelligence center, COVID-19 long haulers, COVID booster shots, and more.
Precision Health Initiative in the News - August 2021
In the last month, the IU Precision Health Initiative researchers have been in the news talking about topics such as an expanded Alzheimer's Disease Scientific Advisory Board, a new study on children who are COVID-19 long-haulers, breakthrough cases and COVID-19 vaccination, and more.
Precision Health Initiative in the News - July 2021
In the last month, the IU Precision Health Initiative researchers have been in the news talking about topics such as the inaugural Tyler Trent charity golf outing to raise money for pediatric cancer research, COVID-19 long-haulers, how to combat vaccination misinformation, and more.
The second IU Grand Challenges webinar about the Precision Health Initiative (PHI) took place this month, focusing on progress in studying and treating childhood sarcomas, which are cancers that develop in the bones and soft tissues. This webinar featured Jamie Renbarger, MD, and Karen Pollok, PhD, co-leaders of the IU Precision Health Initiative pediatric sarcomas disease research team, as well as Tatiana Foroud, PhD, who leads the IU Precision Health Initiative. Kelly and Tony Trent, parents of the late Tyler Trent, also joined the conversation to share Tyler’s journey of fighting osteosarcoma, an aggressive form of bone cancer. IU Vice President for Research Fred Cate served as the event’s host.
Precision Health Initiative in the News - June 2021
In the last month, the IU Precision Health Initiative researchers have been in the news talking about topics such as when we can declare the COVID-19 pandemic over, children with cardiomyopathy and genetic screenings, stigma about mental illness and mass violence, type 2 diabetes, COVID-19 long haulers, and more.
